Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

PURPOSE: Addition of the dipeptidyl peptidase-4 (DPP4) inhibitors to insulin in patients with type 2 diabetes mellitus (T2DM) may achieve better glycemic control. However, results of pilot randomized controlled trials (RCTs) are inconsistent. We aimed to perform a meta-analysis of RCTs to evaluate e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Na, Yang, Tao, Li, Jie, Zhang, Xianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710543/
https://www.ncbi.nlm.nih.gov/pubmed/31692532
http://dx.doi.org/10.2147/DMSO.S202024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710543/
https://www.ncbi.nlm.nih.gov/pubmed/31692532
http://dx.doi.org/10.2147/DMSO.S202024

Ejemplares similares